New anti-inflammatory compounds identified
Nature Medicine
2015년2월17일
Two compounds capable of blocking a component of the immune system (NLRP3) that is involved in several inflammatory disorders are described in two papers published online this week in Nature Medicine. NLRP3 is part of a complex of proteins called the inflammasome, which drives the inflammatory response in several disorders including autoimmune disease, type 2 diabetes, Alzheimer’s disease, atherosclerosis and autoinflammatory disorders.
Vishwa Deep Dixit and colleagues report that β-hydroxybutyrate (BHB), a metabolite produced by the body in response to fasting, high-intensity exercise, caloric restriction or upon consumption of a low-carbohydrate ketogenic diet, can directly inhibit NLRP3. When BHB was packaged in a nanoparticle (to improve its bioavailability in vivo) it reduced inflammation in a mouse model of inflammatory disease, as did administration of a ketogenic diet, which elevated levels of BHB in the bloodstream. These findings suggest that the anti-inflammatory effects of fasting, a ketogenic diet or high-intensity exercise may, in part, be mediated by production of BHB and its inhibition of NLRP3.
In a separate study, Luke O’Neill, Matthew Cooper and colleagues describe a drug, MCC950, which directly inhibits NLRP3. The authors showed that MCC950 is effective at inhibiting inflammatory responses in human cells and in mouse models of autoimmune and autoinflammatory disease. This suggests that the compound may be used to treat a myriad of inflammatory diseases. Furthermore, the anti-inflammatory effects of MCC950 were not associated with inhibition of other components of the inflammasome complex that are important for control of infection.
doi: 10.1038/nm.3804
리서치 하이라이트
-
7월7일
Public health: Tackling adolescent stressNature
-
6월23일
Scientific community: Women credited less than men in scientific paper authorshipNature
-
5월12일
Geoscience: Monitoring earthquakes at the speed of lightNature
-
5월4일
Microbiology: Bacteriophage therapy helps treat multi-drug resistant infection in an immunocompromised patientNature Communications
-
4월27일
Planetary science: Building blocks of DNA detected in meteoritesNature Communications
-
4월8일
Health: Psilocybin use associated with lower risk of opioid addictionScientific Reports